Cardiovascular Needle Market : Global Industry Analysis and Opportunity Assessment, 2036

How big is the Cardiovascular Needle Market in 2026?

USD 113.0 million in 2026, reaching USD 222.3 million by 2036 at a 7.0% CAGR

The cardiovascular needle market is estimated at USD 113.0 million in 2026 and is forecast to reach USD 222.3 million by 2036 at a 7.0% CAGR. Demand is shaped by cardiac surgical volume, where round bodied needles are used for atraumatic suturing in vascular and cardiac procedures. Round Bodied Needles account for 57.3% of Product demand in 2026, while Coronary Artery Bypass Graft Surgery holds 34.9% of applications.

The market was valued at USD 105.6 million in 2025. Growth reflects rising cardiac surgery volume and the shift toward single-use safety needles in hospital settings. Demand is shaped by hospitals and cardiac specialty centers performing bypass and valve procedures that require fine-gauge, atraumatic suturing needles for vascular closure.

Cardiovascular needles are consumable surgical instruments tied directly to cardiac procedure volume. Buyers judge needles through atraumatic performance and single-use safety. Sourcing centers on hospital and cardiac surgical budgets.

Summary of the Cardiovascular Needle Market

Market Signal	Commercial Impact
Demand and Growth Drivers	Demand is tied to cardiac surgery volume, where each procedure consumes single-use atraumatic vascular needles. Hospitals use round bodied needles for atraumatic vascular suturing in coronary artery bypass graft surgery and cardiac procedures. Rising cardiac surgery volume drives recurring single-use needle demand tied to each procedure. Cardiac specialty centers adopt small gauge needles for fine vascular and valve suturing.
Product and Segment View	Round-bodied, single-use needles lead the mix, anchored by coronary artery bypass graft surgery. Round bodied needles account for 57.3% of Product demand, anchored by atraumatic vascular and cardiac suturing. Coronary artery bypass graft surgery leads application at 34.9% share as it is the highest-volume cardiac procedure. Single use leads usage as infection-control practice favors disposable surgical needles.
Geography and Competitive Outlook	South Korea leads growth on cardiac surgery capacity, while majors compete on atraumatic needle quality and supply. South Korea is forecast to record 7.2% CAGR by 2036 due to cardiac surgery capacity and quality procurement. The USA and European Union follow at 7.1% and 7.0% CAGR as cardiac volume and safety adoption sustain demand. Medtronic and Teleflex compete with B. Braun through needle quality and surgical portfolios. Atraumatic performance and supply separate suppliers.
Analyst Opinion	Atraumatic performance paired with reliable single-use supply will win as cardiac surgical volume drives consumable demand. Suppliers that combine atraumatic round bodied needle performance with reliable single-use safety supply will hold the strongest position as cardiac surgical volume drives consumable demand. Adoption is increasing due to single-use safety needles replacing reusable instruments in cardiac surgery. - Anurag Sharma, Principal Consultant at Future Market Insights

Why is the Cardiovascular Needle Market growing?

Rising Round Bodied Needle and bypass-surgery demand in hospital cardiac procedures

• Sustained procurement of round bodied needles is shaped by hospitals performing coronary artery bypass graft and cardiac surgery.
• South Korea is leading the way with growth of 7.2%, driven by cardiac surgery capacity, quality procurement, and single-use adoption.
• The usage segment is led by Single Use as infection-control practice favors disposable needles tied to each procedure.

Demand is rising because cardiac surgical volume requires consumable suturing needles per procedure. Adoption is increasing due to single-use safety needles, which replace reusable instruments to reduce infection risk, with round bodied needles preferred for atraumatic vascular suturing in bypass and valve procedures across hospitals and cardiac specialty centers.

How is the Cardiovascular Needle Market segmented?

By Product, Application, Usage, End User and Size

• Round bodied needles are projected to lead Product demand with 57.3% share in 2026 due to atraumatic vascular suturing.
• Coronary artery bypass graft surgery is expected to lead Application with 34.9% share in 2026 as the highest-volume procedure.
• Hospitals are forecast to lead end user as cardiac surgery concentrates in hospital settings.

Why do round bodied needles lead the Cardiovascular Needle Market?

• Round bodied beedles are expected to hold 57.3% share in 2026 because they provide atraumatic suturing for delicate vascular tissue.
• Their use across bypass and valve procedures anchors cardiac surgical demand.

How big is the application segment in the Cardiovascular Needle Market?

• Coronary artery bypass graft surgery holds 34.9% share, led by high cardiac procedure volume
• Coronary artery bypass graft surgery forms the leading application at 34.9% share, anchored by high procedure volume.
• Open-heart and valve procedures follow as cardiac surgical demand diversifies.

Which usage type leads the market?

• Single use leads usage as infection-control practice favors disposable surgical needles.
• Safety needles follow as hospitals adopt sharps-injury prevention.

Which end user leads procurement?

• Hospitals lead end user as cardiac surgery concentrates in hospital operating rooms.
• Ambulatory surgical and cardiac specialty centers follow as procedure volume extends.

Which size leads the market?

• Small gauge needles lead as fine-gauge needles suit delicate vascular and valve suturing.
• Medium and large gauge needles follow for broader surgical applications.

What drives and restrains the Cardiovascular Needle Market?

Driven by cardiac surgical volume and single-use adoption; restrained by procedure cost and surgical capacity

Cardiac procedure volume and single-use safety adoption support demand while surgical capacity and procedure cost limit access in lower-resource settings.

• Driver: Hospitals performing coronary artery bypass graft and cardiac procedures use round bodied needles for atraumatic vascular suturing, generating recurring single-use demand per procedure.
• Restraint: Cardiac centers in lower-resource settings face surgical capacity and procedure-cost constraints that limit cardiac volume and consumable needle demand.
• Opportunity: Single-use safety needles can widen value by extending sharps-injury prevention across cardiac surgical and ambulatory settings.

Cardiac surgical demand is lifting needle consumption as hospitals perform bypass and valve procedures. Round bodied needles anchor demand while single-use safety needles support infection control.

The market is led by structural demand from hospital cardiac surgery. Round bodied needles remain the leading product, while cutting and specialty needles serve specific uses. Constraints include surgical capacity, procedure cost, and reusable-instrument competition.

Which factors support expansion in the Cardiovascular Needle Market?

Cardiac procedure volume and single-use needle demand support market value across hospital channels

• Market value is supported by single-use needle consumption tied to each cardiac procedure.
• Supplier pricing reflects atraumatic performance and sterility before supply reliability affects renewal.
• Cardiac centers compare needle performance and supply consistency before standardizing on a supplier.

Which countries are growing fastest in the Cardiovascular Needle Market?

Country	CAGR
South Korea	7.2%
USA	7.1%
European Union	7.0%
Japan	6.9%
UK	6.8%

Source: Future Market Insights analysis, 2026.

How do country-level CAGRs compare in the Cardiovascular Needle Market?

The global cardiovascular needle market is projected to expand at 7.0% from 2026 to 2036. The study covers more than 30 countries, and the primary markets are listed below.

• South Korea is forecast to record 7.2% CAGR by 2036 as cardiac surgery capacity and quality procurement expand.
• The USA is expected to expand at 7.1% CAGR through 2036 as cardiac volume and safety adoption sustain demand.
• The European Union is estimated to grow at 7.0% CAGR by 2036 as cardiac surgical activity continues.
• Japan is projected to rise at 6.9% CAGR through 2036 as aging-population cardiac demand grows.
• The UK is forecast to post 6.8% CAGR by 2036 as cardiac surgery and single-use adoption support demand.

Who are the leading companies in the Cardiovascular Needle Market?

Medtronic, Teleflex, B. Braun Melsungen, Ethicon, and MANI

Medtronic and Teleflex compete through surgical needle quality and cardiac portfolio breadth. Atraumatic performance remains a further point of differentiation. B. Braun Melsungen and Ethicon compete on suturing needles, while MANI holds positions in fine-gauge needle manufacturing. These overlap with broader surgical consumable buying paths.

Buyers compare suppliers on atraumatic performance, sterility, and supply reliability. Hospitals standardize on needles with consistent atraumatic quality and reliable single-use supply. Cardiac centers favor suppliers offering fine-gauge needles for delicate vascular suturing.

Who are the key players in the Cardiovascular Needle Market?

Key global companies leading the Cardiovascular Needle Market include:

• Medtronic, Teleflex, and B. Braun Melsungen maintain leading positions through surgical needle portfolios, atraumatic quality, and hospital relationships across global markets.
• Surgical specialists such as Ethicon, MANI, and Peters Surgical compete through suturing needle quality and supply.
• Specialist and emerging providers such as Surgical Specialties Corporation and Healthium Medtech target regional surgical supply to establish positions and scale.

How do top Cardiovascular Needle Market companies compare?

Medtronic and Teleflex lead on scale; B. Braun also has a global footprint, while MANI and Ethicon are more needle-concentrated.

Company	Product Breadth	Atraumatic Quality	Distribution Scale	Geographic Footprint
Medtronic	High	High	Strong	Global
Teleflex	High	High	Strong	Global
B. Braun Melsungen	High	Moderate	Strong	Europe-led
Ethicon	Moderate	High	Strong	Global
MANI	Moderate	High	Moderate	Asia-led

Source: Future Market Insights competitive analysis, 2026.

Key Developments in the Cardiovascular Needle Market

• In April 2025, CIRCA Scientific received FDA 510(k) clearance for the PeriCross Epicardial Access Kit, combining a tine-based retraction mechanism with a 21-gauge micro-puncture needle to separate pericardium from myocardium before needle advancement. Purpose-built access kits displace improvised Tuohy needle technique in epicardial procedures. Design evidence supports electrophysiology labs assessing perforation risk before standardising access protocols. 

• In April 2025, CardioVia received FDA clearance for ViaOne, which retracts the pericardium so a concealed blunt-tip needle can reach the pericardial space, with integrated sensors tracking device position. Concealed-tip designs reframe safety expectations for cardiac access needles. Perforation-reduction evidence supports interventional cardiologists comparing access technologies before adopting new arrhythmia workflows. 

• In December 2025, Atraverse Medical secured FDA 510(k) clearance for the fully integrated HOTWIRE Transseptal Access System, a zero-exchange, sheath-agnostic radiofrequency guidewire platform with impedance-guided shutoff, following nearly 2,000 clinical procedures with its guidewire. Radiofrequency guidewire crossing competes directly with conventional needle-based transseptal puncture. Substitution evidence supports procurement teams evaluating whether needle inventory requirements will decline. 

Key Players in the Cardiovascular Needle Market

Global Surgical Leaders

• Medtronic plc
• Teleflex Incorporated
• B. Braun Melsungen AG

Suturing Needle Specialists

• Ethicon, Inc. (Johnson & Johnson MedTech)
• MANI, Inc.
• Peters Surgical
• Surgical Specialties Corporation

Regional and Emerging Players

• Sutures India Pvt. Ltd. (HealthiumMedtech)
• Advanced Medical Solutions Group plc
• Kono Seisakusho Co., Ltd.

Cardiovascular Needle Market - Scope & Definition

Attribute	Detail
Market Definition	Surgical needles used for suturing in cardiovascular and cardiac procedures, spanning round bodied, cutting, and specialty needle types across usage and gauge sizes
Functions Covered	Vascular suturing, cardiac tissue closure, and atraumatic suturing across cardiac procedures
Applications Covered	Coronary artery bypass graft, open-heart surgery, cardiac valve procedures, heart transplant, and vascular surgery
End-Use Industries	Hospitals, ambulatory surgical centers, clinics, and cardiac specialty centers
Inclusions	Round bodied, cutting, suturing, cannulation, and specialty cardiac needles across single-use and safety formats
Exclusions	Non-cardiac surgical needles, injection needles outside surgery, and diagnostic biopsy devices outside cardiac use

Cardiovascular Needle Market - Research Methodology

Method	Description
Primary Research	FMI analysts gathered input from manufacturers, service providers, technology developers, distributors, end users, procurement teams, and subject-matter experts. Interviews examined purchasing decisions, product or service evaluation, adoption barriers, approval requirements, pricing considerations, and expectations for technical or commercial support. Respondents were also asked what evidence is required before a trial, pilot, or initial order develops into regular purchasing.
Desk Research	Desk research covered government statistics, regulatory publications, trade data, industry associations, technical literature, standards, company filings, product information, and official corporate announcements. Sources were reviewed for relevance, publication date, geographic coverage, and consistency with the defined market scope. Claims relating to performance, applications, approvals, capacity, investment, and commercial activity were retained only when supported by credible public evidence.
Market Sizing & Forecasting	The market model combined the baseline value with historical performance, segment structure, pricing and volume indicators, adoption levels, company participation, and country-level demand conditions. Forecast assumptions considered economic activity, investment trends, regulatory developments, technology adoption, purchasing cycles, supply availability, and barriers to wider market use. Segment and regional estimates were reconciled before the final market total was calculated.
Data Validation	Estimates were checked against multiple independent indicators, including public data, company activity, trade patterns, industry developments, and findings from primary interviews. Validation also tested whether products, services, applications, and company revenues fell within the defined market boundaries. Adjacent categories, unsupported claims, overlapping revenues, and activities without direct market relevance were excluded to reduce double counting and maintain consistency across segments and countries.

What does the Cardiovascular Needle Market report cover?

2021 to 2025 history and 2026 to 2036 forecasts across all segments and 30+ countries

Parameter	Details
Forecast period	2026 to 2036
Historical period	2021 to 2025
Quantitative unit	Value in USD million
By Product	Round Bodied Needles, Cutting Needles, Suturing Needles, Cannulation Needles, Biopsy and Aspiration Needles, Specialty Needles
By Application	Coronary Artery Bypass Graft Surgery, Open-heart Surgery, Cardiac Valve Procedures, Heart Transplant, Vascular Surgery, Interventional Cardiology
By Usage	Single Use, Multiple Use, Safety Needles
By End user	Hospitals, Ambulatory Surgical Centers, Clinics, Cardiac Specialty Centers, Emergency Care Centers
By Size	Small Gauge Needles, Medium Gauge Needles, Large Gauge Needles
Regions covered	North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries covered	USA, South Korea, European Union, Japan, UK, and other major markets
Key companies profiled	Medtronic, Teleflex, B. Braun Melsungen, Ethicon, MANI, Peters Surgical, Surgical Specialties, Healthium Medtech
Approach	Bottom-up procedure-based approach using cardiac volume, needle use per procedure, product mix, and supplier disclosures

Market Segmentation Analysis

Cardiovascular Needle Market Segmented by Product:

• Round Bodied Needles
• Cutting Needles
  • Tough Tissue Penetration
  • Valve Repair Procedures
• Suturing Needles
  • Taper Point Needles
    • Soft Tissue Cardiac Closure
    • Vascular Anastomosis Use
  • Blunt Needles
    • Fragile Tissue Handling
    • Reduced Needlestick Risk
• Cannulation Needles
  • Arterial Cannulation Needles
    • Cardiopulmonary Bypass Access
    • High Flow Arterial Entry
  • Venous Cannulation Needles
    • Central Venous Access
    • Bypass Venous Drainage
  • Percutaneous Access Needles
    • Guidewire Introduction Use
    • Minimally Invasive Entry
• Biopsy and Aspiration Needles
  • Myocardial Biopsy Needles
  • Pericardiocentesis Needles
• Specialty Needles
  • Micro Needles
  • Preloaded Needle Systems

Cardiovascular Needle Market Segmented by Application:

• Coronary Artery Bypass Graft Surgery
  • Graft Vessel Suturing
  • Chest Closure Support
• Open-heart Surgery
• Cardiac Valve Procedures
• Heart Transplant
• Vascular Surgery
  • Aneurysm Repair
    • Aortic Reconstruction Use
    • Peripheral Vessel Repair
  • Endarterectomy Procedures
    • Carotid Artery Surgery
    • Plaque Removal Closure
• Interventional Cardiology
  • Catheter Based Access
    • Percutaneous Entry Use
    • Guidewire Support Access
  • Device Implantation
    • Lead Placement Support
    • Structural Heart Access
• Emergency Procedures
  • Pericardiocentesis
    • Cardiac Tamponade Relief
    • Emergency Drainage Use
  • Trauma Care
• Others

Cardiovascular Needle Market Segmented by Usage:

• Single Use
  • Infection Control Priority
  • Routine Hospital Use
• Multiple Use
  • Autoclavable Needles
    • Premium Surgical Sets
    • Repeated OR Use
  • Specialty Reusable Systems
    • High Precision Cardiac Needles
    • Institutional Cost Saving Use
• Safety Needles
  • Shielded Needles
    • Needlestick Prevention Use
    • Staff Safety Programs
  • Retractable Needles
    • Post Use Protection
    • High Compliance Facilities

Cardiovascular Needle Market Segmented by End User:

• Hospitals
  • Public Hospitals
    • Government Cardiac Centers
    • Teaching Hospitals
  • Private Hospitals
    • Multi Specialty Cardiac Units
    • Advanced Surgical Theaters
• Ambulatory Surgical Centers
  • Day Procedure Centers
    • Minor Vascular Procedures
    • Short Stay Cardiac Cases
  • Specialty Outpatient Centers
    • Elective Interventions
    • Follow Up Procedures
• Clinics
• Cardiac Specialty Centers
  • Heart Institutes
    • High Volume CABG Centers
    • Valve Surgery Programs
  • Cath Labs
    • Interventional Cardiology Units
    • Hybrid OR Facilities
• Emergency Care Centers
  • Trauma Centers
  • Urgent Care Hospitals
• Others

Cardiovascular Needle Market Segmented by Size:

• Small Gauge Needles
  • Fine Precision Needles
    • Microsurgery Applications
    • Pediatric Procedures
  • Short Length Needles
    • Superficial Vessel Access
    • Delicate Tissue Use
• Medium Gauge Needles
  • Standard Procedure Needles
    • Routine Cardiac Surgery Use
    • General Vascular Access
  • Medium Length Needles
    • Balanced Control Use
    • Multi Purpose Applications
• Large Gauge Needles
  • High Flow Access Needles
    • Cannulation Procedures
    • Rapid Fluid Exchange Use
  • Long Length Needles
    • Deep Access Procedures
    • Thoracic Use Cases

Cardiovascular Needle Market by Region:

• North America
  • USA
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Türkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa

Research Sources and Bibliography

• World Health Organization. (2025, October). Global report on cardiovascular disease and surgical capacity.
• Organisation for Economic Co-operation and Development. (2025, November). Health at a Glance: surgical procedure volumes.
• U.S. Food and Drug Administration. (2026, February 9). Device clearances for surgical suturing needles.
• European Commission. (2025, December 6). Medical Device Regulation guidance for surgical instruments.
• National Health Commission of China. (2025, September). Cardiac surgery capacity bulletin.
• Medtronic plc. (2026, February 18). 2025 annual report and surgical portfolio overview.
• Teleflex Incorporated. (2026, February 20). 2025 results and surgical products update.

This bibliography is provided for reader reference and is not exhaustive.

This Report Answers

• Market size estimates for 2026 and forecasts through 2036 for the Cardiovascular Needle Market.
• Analysis of product demand across round bodied and cutting needles with usage mix.
• Country-level growth analysis covering South Korea and the USA with European Union, Japan and UK outlooks.
• Evaluation of company positioning across Medtronic and Teleflex with B. Braun, Ethicon and MANI.
• Assessment of drivers and restraints with procurement patterns across hospital and cardiac surgical channels.